Drugs, Otc Drug | featured news

HHS overrules FDA, blocks over-the-counter Plan B for younger teens

Plan B Emergency Contraceptive

The emergency contraceptive Plan B will not be made available over-the-counter to younger teens, the Food and Drug Administration announced today, exposing a rift between the agency and the U.S. Department of Health and Human Services.

 

Deaths from painkiller overdose triple in decade

A new government report shows the number of overdose deaths from powerful painkillers have more than tripled over a decade....

 

Walgreen fiscal 4th-qtr profit jumps 69 percent

Drugstore operator Walgreen Co. says its fiscal fourth-quarter profit jumped 69 percent, boosted in part by a gain from the sale of its pharmacy benefits management business.

 

Pfizer Is Said to Pursue Nonprescription Lipitor

Pfizer hopes to have an over-the-counter version of the world’s best-selling drug after it loses patent protection.

 

Shortage of ADHD drugs gives parents the jitters

Nationwide shortages of popular drugs used to treat ADD and ADHD are sending parents scrambling, with some combing multiple pharmacies for the Adderall and Ritalin that keep their kids calm.

 

J&J recall saga continues with Children's Benadryl

Johnson & Johnson's McNeil unit has begun a voluntary recall of Children's Benadryl allergy tablets, in cherry and grape flavors, citing insufficiencies in the development of the manufacturing process.

 

F.D.A. Pulls Painkiller Due to Risks

The maker of the painkiller Darvon is pulling the drug off the market at the request of public health officials who say the 50-year-old pill causes potentially deadly heart rhythms.

 

FDA rejects anticipated diet pill Qnexa

FDA rejects anticipated diet pill Qnexa

Federal health regulators have decided not to approve an experimental diet pill called Qnexa, which had been touted by many experts as the most promising weight-loss drug in more than a decade.

 

Pfizer to buy King Pharma for $3.6 billion in cash

Pfizer to buy King Pharma for $3.6 billion in cash

Pfizer Inc, the world's biggest drugmaker, has agreed to buy King Pharmaceuticals Inc for $3.6 billion, expanding its presence in the market for pain drugs.

 

Subscribe to this RSS topic: Syndicate content